IS7178A - Skynmatshæfar samsetningar sem leysast upp í munni - Google Patents

Skynmatshæfar samsetningar sem leysast upp í munni

Info

Publication number
IS7178A
IS7178A IS7178A IS7178A IS7178A IS 7178 A IS7178 A IS 7178A IS 7178 A IS7178 A IS 7178A IS 7178 A IS7178 A IS 7178A IS 7178 A IS7178 A IS 7178A
Authority
IS
Iceland
Prior art keywords
sensible
watering
formulations
mouth
watering formulations
Prior art date
Application number
IS7178A
Other languages
English (en)
Icelandic (is)
Inventor
T. Le Trang
C. Ludwig Blake
P. Reo Joseph
J. Shah Uday
Yamamoto Ken
Original Assignee
Pharmacia Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corporation filed Critical Pharmacia Corporation
Publication of IS7178A publication Critical patent/IS7178A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Physiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IS7178A 2001-09-26 2004-03-11 Skynmatshæfar samsetningar sem leysast upp í munni IS7178A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32535601P 2001-09-26 2001-09-26
PCT/US2002/030048 WO2003026697A2 (en) 2001-09-26 2002-09-23 Organoleptically acceptable intraorally disintegrating compositions

Publications (1)

Publication Number Publication Date
IS7178A true IS7178A (is) 2004-03-11

Family

ID=23267542

Family Applications (2)

Application Number Title Priority Date Filing Date
IS7178A IS7178A (is) 2001-09-26 2004-03-11 Skynmatshæfar samsetningar sem leysast upp í munni
IS7177A IS7177A (is) 2001-09-26 2004-03-11 Valdekoxíb samsetningar sem leysast upp í munni

Family Applications After (1)

Application Number Title Priority Date Filing Date
IS7177A IS7177A (is) 2001-09-26 2004-03-11 Valdekoxíb samsetningar sem leysast upp í munni

Country Status (25)

Country Link
US (1) US20030181501A1 (enExample)
EP (2) EP1429736A2 (enExample)
JP (2) JP2005512964A (enExample)
KR (2) KR20040058189A (enExample)
CN (2) CN1633281A (enExample)
AP (2) AP2004002999A0 (enExample)
AR (1) AR037239A1 (enExample)
BR (2) BR0212778A (enExample)
CA (2) CA2461044A1 (enExample)
CO (2) CO5570684A2 (enExample)
EA (2) EA200400357A1 (enExample)
EC (1) ECSP045029A (enExample)
GE (1) GEP20063856B (enExample)
HK (1) HK1079988A1 (enExample)
IL (2) IL160855A0 (enExample)
IS (2) IS7178A (enExample)
MA (2) MA27682A1 (enExample)
MX (2) MXPA04002652A (enExample)
NO (2) NO20041258L (enExample)
OA (2) OA12707A (enExample)
PL (2) PL369298A1 (enExample)
TN (2) TNSN04045A1 (enExample)
WO (2) WO2003026623A1 (enExample)
YU (1) YU34804A (enExample)
ZA (2) ZA200401953B (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005002557A1 (en) * 2003-07-03 2005-01-13 Warner-Lambert Company Llc Pharmaceutical compositions including an ether and selective cox-2 inhibitor and uses thereof
US20050186271A1 (en) * 2004-02-24 2005-08-25 Sheskey Paul J. Process for dispersing a fluid in a mass of solid particles
JP5551852B2 (ja) * 2004-08-10 2014-07-16 味の素株式会社 苦味の低減したナテグリニド含有製剤
EP1839650A1 (en) * 2004-12-28 2007-10-03 Eisai R&D Management Co., Ltd. Quick disintegration tablet and method of producing the same
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US20100015221A1 (en) * 2005-12-20 2010-01-21 Eisai R&D Management Co.Ltd. Orally rapid disintegrating tablet preparation comprising fat-soluble active ingredients
US8535714B2 (en) 2006-01-06 2013-09-17 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US8202535B2 (en) 2006-01-06 2012-06-19 Acelrx Pharmaceuticals, Inc. Small-volume oral transmucosal dosage forms
US8865743B2 (en) * 2006-01-06 2014-10-21 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US8252329B2 (en) 2007-01-05 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
WO2007087188A2 (en) * 2006-01-20 2007-08-02 Merck & Co., Inc. Taste-masked tablets and granules
US20070196494A1 (en) * 2006-02-17 2007-08-23 Arnaud Grenier Low-friability, patient-friendly orally disintegrating formulations
CA2687124A1 (en) * 2006-05-19 2007-12-13 Somaxon Pharmaceuticals, Inc. Low dose doxepin formulations, including buccal, sublingual and fastmelt formulations, and uses of the same to treat insomnia
JP5420535B2 (ja) * 2007-06-06 2014-02-19 ビーエーエスエフ ソシエタス・ヨーロピア 速崩性錠剤製造のための医薬製剤
US8568780B2 (en) * 2007-06-06 2013-10-29 Basf Se Pharmaceutical formulation for the production of rapidly disintegrating tablets
JP2010529073A (ja) * 2007-06-06 2010-08-26 ビーエーエスエフ ソシエタス・ヨーロピア チュアブル錠及びトローチ剤製造のための医薬製剤
WO2008148742A2 (de) * 2007-06-06 2008-12-11 Basf Se Pharmazeutische formulierung für die herstellung von schnell zerfallenden tabletten
KR101606944B1 (ko) * 2007-08-07 2016-03-28 아셀알엑스 파마슈티컬스 인코퍼레이티드 경구 경점막 투여형을 사용한 시술시 진정과 무통을 위한 조성물 및 방법
EP2268268A2 (en) * 2008-03-24 2011-01-05 Wockhardt Research Centre Orally disintegrating compositions of rhein or diacerein
US8945592B2 (en) * 2008-11-21 2015-02-03 Acelrx Pharmaceuticals, Inc. Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
CN102988318A (zh) * 2008-11-25 2013-03-27 田边三菱制药株式会社 口腔速崩片及其制备方法
WO2010144865A2 (en) 2009-06-12 2010-12-16 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
US20110091544A1 (en) * 2009-10-16 2011-04-21 Acelrx Pharmaceuticals, Inc. Compositions and Methods for Mild Sedation, Anxiolysis and Analgesia in the Procedural Setting
FR2968995B1 (fr) * 2010-12-16 2013-03-22 Sanofi Aventis Composition pharmaceutioue pour une administration par voie orale destinee a eviter le mesusage
CN106822007B (zh) 2015-09-11 2021-12-31 西姆莱斯股份公司 口服制剂

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
US5576014A (en) * 1994-01-31 1996-11-19 Yamanouchi Pharmaceutical Co., Ltd Intrabuccally dissolving compressed moldings and production process thereof
US5633272A (en) * 1995-02-13 1997-05-27 Talley; John J. Substituted isoxazoles for the treatment of inflammation
SK74396A3 (en) * 1995-06-13 1997-04-09 American Home Prod Organoleptically acceptable oral pharmaceutical compositions
JPH11513641A (ja) * 1995-10-20 1999-11-24 ファルマシア・アンド・アップジョン・カンパニー ブリスターパッケージ
KR100373622B1 (ko) * 1996-05-17 2003-07-12 머크 앤드 캄파니 인코포레이티드 사이클로옥시게나제-2로매개된질환의1일1회치료용조성물
EP0863134A1 (en) * 1997-03-07 1998-09-09 Merck Frosst Canada Inc. 2-(3,5-difluorophenyl)-3-(4-(methyl-sulfonyl)phenyl)-2-cyclopenten-1-one useful as an inhibitor of cyclooxygenase-2
US6465009B1 (en) * 1998-03-18 2002-10-15 Yamanouchi Pharmaceutical Co., Ltd. Water soluble polymer-based rapidly dissolving tablets and production processes thereof
CN1679556A (zh) * 1999-12-08 2005-10-12 法马西亚公司 维得克西组合物
US6316029B1 (en) * 2000-05-18 2001-11-13 Flak Pharma International, Ltd. Rapidly disintegrating solid oral dosage form
US6800297B2 (en) * 2000-06-15 2004-10-05 Acusphere, Inc. Porous COX-2 inhibitor matrices and methods of manufacture thereof
PT1309315E (pt) * 2000-08-18 2006-09-29 Pharmacia Corp Formulacao oral de desintegracao rapida de valdecoxib
CN1638739A (zh) * 2000-08-18 2005-07-13 法玛西雅厄普约翰美国公司 治疗成瘾性障碍的化合物

Also Published As

Publication number Publication date
CO5570659A2 (es) 2005-10-31
MXPA04002798A (es) 2004-07-05
ZA200402364B (en) 2005-01-13
ECSP045029A (es) 2004-04-28
GEP20063856B (en) 2006-06-26
IS7177A (is) 2004-03-11
TNSN04047A1 (fr) 2006-06-01
AP2004002999A0 (en) 2004-03-31
OA12707A (en) 2006-06-26
CA2461630A1 (en) 2003-04-03
HK1079988A1 (zh) 2006-04-21
IL160848A0 (en) 2004-08-31
EA200400357A1 (ru) 2004-08-26
MA27682A1 (fr) 2006-01-02
CO5570684A2 (es) 2005-10-31
NO20041258L (no) 2003-03-27
WO2003026697A3 (en) 2003-07-03
EP1490035A1 (en) 2004-12-29
MXPA04002652A (es) 2004-06-07
KR20040058189A (ko) 2004-07-03
AP2004002998A0 (en) 2004-03-31
NO20041532L (no) 2004-04-15
YU34804A (sh) 2006-08-17
EA200400352A1 (ru) 2004-12-30
OA13060A (en) 2006-11-10
AR037239A1 (es) 2004-11-03
WO2003026697A2 (en) 2003-04-03
JP2005506987A (ja) 2005-03-10
CA2461044A1 (en) 2003-04-03
WO2003026623A8 (en) 2004-09-30
MA27542A1 (fr) 2005-10-03
JP2005512964A (ja) 2005-05-12
CN1633281A (zh) 2005-06-29
IL160855A0 (en) 2004-08-31
PL369298A1 (en) 2005-04-18
PL369297A1 (en) 2005-04-18
KR20040044990A (ko) 2004-05-31
CN1703203A (zh) 2005-11-30
EP1429736A2 (en) 2004-06-23
BR0212778A (pt) 2004-12-07
ZA200401953B (en) 2005-05-09
BR0212861A (pt) 2004-10-05
WO2003026623A1 (en) 2003-04-03
TNSN04045A1 (fr) 2006-06-01
US20030181501A1 (en) 2003-09-25

Similar Documents

Publication Publication Date Title
IS7178A (is) Skynmatshæfar samsetningar sem leysast upp í munni
ATE303787T1 (de) Schergelzusammensetzungen
DE60223654D1 (de) Resistzusammensetzung
AR028197A1 (es) Composiciones antitranspirantes
FI20010780A0 (fi) Parannetut koostumukset
IS6915A (is) Lyfjablanda
DE60201775D1 (de) Leistungsschalter
ATE476975T1 (de) Abführende zusammensetzungen
IS2932B (is) Fúlvestrant samsetning
ATE289796T1 (de) Orale zusammensetzung
DE60238231D1 (de) Leitfähige Zusammensetzung
BR0210619A (pt) composição
IS7081A (is) Lyfjablanda
ATE369830T1 (de) Schweisshemmende zusammensetzungen
ATE314049T1 (de) Schweisshemmende zusammensetzungen
NO20034695D0 (no) Nye sammensetninger
IS6951A (is) Bífenýlkarboxamíð sem lækka fitu
DE60232427D1 (de) Polyacrylatzusammensetzung
DE60116858D1 (de) Zusammensetzung
EP1420818A4 (en) ANTIGENIC COMPOSITIONS
NO20023976L (no) Endoparasittiske sammensetninger
ITTO20020744A0 (it) Composizione
DE60200104D1 (de) Desodorierende Zusammensetzung
IS6857A (is) Lyfjafræðileg samsetning sem innheldur sítalópram
DE60221447D1 (de) Trennmodul